112 related articles for article (PubMed ID: 1320272)
21. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
22. Measurement of individual aflatoxin exposure among people having different risk to primary hepatocellular carcinoma.
Sun TT; Wu SM; Wu YY; Chu YR
Princess Takamatsu Symp; 1985; 16():225-35. PubMed ID: 3025163
[TBL] [Abstract][Full Text] [Related]
23. Detection of exposure to aflatoxin in an African population.
Autrup H; Wakhisi J
IARC Sci Publ; 1988; (89):63-6. PubMed ID: 3143673
[TBL] [Abstract][Full Text] [Related]
24. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
25. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
[TBL] [Abstract][Full Text] [Related]
27. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
28. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
29. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
Irvin TR; Wogan GN
Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
[TBL] [Abstract][Full Text] [Related]
30. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
31. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
[TBL] [Abstract][Full Text] [Related]
32. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China.
Kensler TW; Chen JG; Egner PA; Fahey JW; Jacobson LP; Stephenson KK; Ye L; Coady JL; Wang JB; Wu Y; Sun Y; Zhang QN; Zhang BC; Zhu YR; Qian GS; Carmella SG; Hecht SS; Benning L; Gange SJ; Groopman JD; Talalay P
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2605-13. PubMed ID: 16284385
[TBL] [Abstract][Full Text] [Related]
33. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
34. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
Wild CP; Montesano R
Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
[TBL] [Abstract][Full Text] [Related]
35. [Detection of aflatoxin-albumin adducts in human serum and its application].
Sun G; He X; Qian G; Pu Y
Wei Sheng Yan Jiu; 2001 May; 30(3):185-8. PubMed ID: 12525098
[TBL] [Abstract][Full Text] [Related]
36. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
[TBL] [Abstract][Full Text] [Related]
37. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
Hsieh LL; Hsu SW; Chen DS; Santella RM
Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
[TBL] [Abstract][Full Text] [Related]
38. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Harris CC; Sun TT
Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
Groopman JD; Scholl P; Wang JS
Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
[No Abstract] [Full Text] [Related]
40. Dietary risk factors for primary hepatocellular carcinoma.
Wogan GN
Cancer Detect Prev; 1989; 14(2):209-13. PubMed ID: 2559796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
